Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

Thursday, 21 July 2016, 9:46 pm

I see Bloomberg was today badgering Dr Severin Schwan, the Roche chief executive, into providing a denial to my BioMarin story from a few weeks ago.

According to the Bloomberg story I read today, Dr Schwan said Roche was looking at small to medium-sized acquistions although he believes biotech valuations are "too high" even after the recent market correction.

But when the Bloomberg hack tried to elicit a denial or confirmation by asking spefically about Roche's interest in BioMarin Dr Schwan declined to comment.

I wonder why.....

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Post Comment